Biocon surges as its arm collaborates with DKSH

22 Jun 2020 Evaluate
Biocon is currently trading at Rs. 387.50, up by 6.00 points or 1.57% from its previous closing of Rs. 381.50 on the BSE.

The scrip opened at Rs. 382.00 and has touched a high and low of Rs. 389.10 and Rs. 382.00 respectively. So far 153776 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 404.50 on 18-Jun-2020 and a 52 week low of Rs. 211.30 on 20-Aug-2019.

Last one week high and low of the scrip stood at Rs. 404.50 and Rs. 378.10 respectively. The current market cap of the company is Rs. 46122.00 crore.

The promoters holding in the company stood at 60.67%, while Institutions and Non-Institutions held 22.30% and 17.03% respectively.

Biocon’s subsidiary--Biocon Pharma and DKSH Business Unit Healthcare, have signed an agreement under which DKSH will sell and distribute seven of Biocon Pharma’s generic formulations in Singapore and Thailand. This development is in line with Biocon’s strategy for expansion of its generic formulations business through licensing of its drug products in multiple markets. Thailand and Singapore are the two large markets in the South East Asia region.

Under the terms of the agreement, DKSH will gain an exclusive license to register and commercialize these seven generic formulations from various therapeutic areas like diabetology, cardiology, oncology and immunology, which will be sold under Biocon’s brand in Singapore and Thailand. DKSH will manage marketing and sales as well as logistics for Biocon Pharma, helping drive sales growth through its capabilities and strengths in the medical and pharmacy channels.

Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovationdriven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.

Biocon Share Price

365.25 -1.15 (-0.31%)
27-Jan-2026 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1636.05
Dr. Reddys Lab 1240.00
Cipla 1313.20
Zydus Lifesciences 895.85
Lupin 2147.60
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×